• 1
    Lowenstein DH, Alldredge BK. Current concepts-status epilepticus. New Engl J Med 1998; 338: 970976.
  • 2
    Chittajallu R, Braithwaite SP, Clarke VRJ, Henley JM. Kainate receptors: subunits, synaptic localization and function. Trends Pharmacol Sci 1999; 20: 2635.
  • 3
    Virgili M, Migan P, Contestabile A, Barnabei O. Protection from kainic acid neuropathological syndrome by NMDA receptor antagonists: effect of MK-801 and CGP39551 on neurotransmitter and glial markers. Neuropharmacology 1992; 31: 469474.
  • 4
    Lees GJ. Effects of anesthetics, anticonvulsants and glutamate antagonists on kainic acid-induced local and distal neuronal loss. Neurol Sci 1992; 108: 221228.
  • 5
    Olney JW, Rhee V, Ho OL. Kainic acid: a powerful neurotoxic analogue of glutamate. Brain Res 1974; 77: 507515.
  • 6
    Sperk G, Lassmann H, Baran H, Kish SJ, Seitelberger F, Hornykiewicz O. Kainic acid induced seizures: neurochemical and histopathological changes. Neuroscience 1983; 10: 13011315.
  • 7
    Ferkany JW, Zaczek R, Coyle JT. Kainic acid stimulates excitatory amino acid neurotransmitter release at presynaptic receptors. Nature 1982; 298: 757759.
  • 8
    Palmer AM, Reiter CT, Botscheller M. Comparison of the release of exogenous and endogenous excitatory amino acids from rat cerebral cortex. Ann NY Acad Sci 1992; 648: 361364.
  • 9
    Coyle JT, Puttfarcken P. Oxidative stress, glutamate and neurodegenerative disorders. Science 1993; 262: 689695.
  • 10
    Dykens JA, Stern A, Trenkner E. Mechanisms of kainate toxicity to cellular neurons in vitro as analogous to reperfusion tissue injury. J Neurochem 1987; 49: 12221228.
  • 11
    Matsuoka Y, Kitamura Y, Kakikura J, Taniguchi T. Expression of heme oxygenase-1 mediated by non-NMDA and metabotropic receptors in glial cells: possible involvement of reactive oxygen species production and protein kinase C activation. Neuropharmacology 1999; 38: 825834.
  • 12
    Colton CA, Gilbert DL. Production of superoxide anions by a CNS macrophage, the microglia. FEBS Lett 1987; 223: 284288.
  • 13
    Reiter RJ. Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol 1998; 56: 359384.
  • 14
    Gilad E, Cuzzocrea S, Zingarelli B, Salzman AL, Szabo C. Melatonin is a scavenger of peroxinitrite. Life Sci 1997; 60: PL169PL174.
  • 15
    Cuzzocrea S, Zingarelli B, Gilard E, Hake P, Salzman AL, Szabo C. Anti-inflammatory effects of mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, in carrageenan-induced models of inflammation. Free Rad Biol Med 1998; 24: 450459.
  • 16
    Tan DX, Manchester LC, Reiter RJ, Qi WB, Kim SJ, Elsokkary GH. Melatonin protects hippocampal neurons in vivo against kainic acid-induced damage in mice. J Neurosci Res 1998; 54: 382389.
  • 17
    Giust P, Lipartiti M, Franceschin D, Schiavo N, Floreani M. Neuroprotection by melatonin from kainate-induced excitotoxicity in rats. FASEB J 1996; 10: 891896.
  • 18
    Uz T, Giusti P, Franceschini D, Kharlamov A, Manev H. Protective effect of melatonin against hippocampal DNA damage induced by intraperitoneal administration of kainate to rats. Neuroscience 1996; 73: 631636.
  • 19
    Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Academic Press, New York,1986.
  • 20
    Streit WJ. An improved staining method for rat microglial cells using the lectin from Griffonia simplicifolia (GSA I-B4). J Histochem Cytochem 1990; 381: 683686.
  • 21
    Kreuzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996; 19: 312318.
  • 22
    Nalder JV, Perry BW, Gentry C, Cotman CW. Degeneration of hippocampal CA3 pyramidal cells induced by intraventricular kainic acid. J Comp Neurol 1980; 92: 333359.
  • 23
    Keller JN, Mattson MP. Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in nervous system. Rev Neurosci 1998; 9: 105116.
  • 24
    Mrak RE, Sheng JG, Griffin WS. Glial cytokines in Alzheimer's disease: review and pathogenic implications. Human Pathol 1991; 26: 816823.
  • 25
    Kruman I, Bruce-Keller AJ, Bredesen D, Waeg G, Mattson MP. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J Neurosci 1997; 17: 50895100.
  • 26
    Waeg G, Dimsity G, Esterbauer H. Monoclonal antibodies for detection of 4-hydroxynonenal modified proteins. Free Rad Res 1996; 25: 149159.
  • 27
    Melchiorri D, Reiter RJ, Sewerynek E, Chen LD, Nistico G. Melatonin reduces kainate-induced lipid peroxidation in homogenates of different brain regions. FASEB J 1995; 9: 12051210.
  • 28
    Wasterlain CG, Fujikawa DG, Penix L, Sankar R. Pathophysiological mechanism of brain damage from status epilepticus. Epilepsia 1983; 34: S37S53.
  • 29
    Bengzon J, Kokaia Z, Elmer E, Nanobashvili A, Kokaia M, Lindvall O. Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures. Proc Natl Acad Sci USA 1997; 94: 1043210437.
  • 30
    Menendez-Pelaez A, Reiter RJ. Distribution of melatonin in mammalian tissues: the relative importance of nuclear versus cytosolic localization. J Pineal Res 1993; 15: 5969.
  • 31
    Tan DX, Chen LD, Poeggeler B, et al. Melatonin: a potent endogenous hydroxyl radical scavenger. Endocr J 1993; 1: 5760.
  • 32
    Reiter RJ. Acuna-Castroviejo D, Tan DX, Burkhardt S. Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system. Ann NY Acad Sci 2001; 939: 200215.
  • 33
    Li XJ, Gu J, Lu SD, et al. Melatonin attenuates MPTP-induced dopaminergic neuronal injury associated with scavenging hydroxyl radical. J Pineal Res 2002; 32: 4752.
  • 34
    Hsu CH, Chi BC, Casida JE. Melatonin reduces phosphine-induced lipid and DNA oxidation in vitro and in vivo in rat brain. J Pineal Res 2002; 32: 5358.
  • 35
    Shen YX, Xu SY, Wei W, et al. The protective effects of melatonin from oxidative damage induced by amyloid beta-peptide 25–35 in middle-aged rats. J Pineal Res 2002; 32: 8589.
  • 36
    Pappolla MA, Simovich MJ, Bryant-Thomas T, et al. The neuroprotective activities of melatonin against the Alzheimer beta-protein are not mediated by melatonin membrane receptors. J Pineal Res 2002; 32: 135142.
  • 37
    Pei Z, Pang SF, Cheung RT. Pretreatment with melatonin reduces volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model. J Pineal Res 2002; 32: 168172.